Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients

The aim of this retrospective cohort study was to compare safety, efficacy and rates and reasons of discontinuation of the 3 currently approved integrase strand transfer inhibitors (INSTIs) elvitegravir (EVG), dolutegravir (DTG), and raltegravir (RAL) in HIV-infected treatment-naïve and -experienced...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Brehm, Thomas Theo, Franz, Marleen, Hüfner, Anja, Hertling, Sandra, Schmiedel, Stefan, Degen, Olaf, Kreuels, Benno, Schulze zur Wiesch, Julian
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6708907/
https://ncbi.nlm.nih.gov/pubmed/31393378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016721
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars